| 1 |
What is the primary function of AI in the medical imaging industry?
|
To improve diagnostic accuracy and patient outcomes |
|
The primary function of AI in the medical imaging industry is To Improve Diagnostic Accuracy And Patient Outcomes. AI technologies enhance the interpretation of medical images, assist in detecting and diagnosing conditions more accurately, and can help tailor treatment plans to individual patients, ultimately leading to better health outcomes |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following is a key benefit of AI in radiology noted in the article?
|
Acts as a second medical opinion |
|
A key benefit of AI in radiology noted in the article is that it Acts As A Second Medical Opinion. AI systems can provide additional diagnostic insights and support radiologists by offering a secondary perspective on medical images, which can enhance diagnostic accuracy and confidence |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What does AI literacy refer to according to the article?
|
Understanding and knowledge of AI technology |
|
According to the article, AI literacy refers to Understanding And Knowledge Of AI Technology. This encompasses having a grasp of how AI works, its applications, and its implications, which is crucial for effectively interacting with and utilizing AI systems in various fields |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which factor is NOT listed as influencing the acceptability of AI among healthcare professionals?
|
The color of the AI machines |
|
The factor that is NOT listed as influencing the acceptability of AI among healthcare professionals is The Color Of The AI Machines. The acceptability of AI in healthcare is generally influenced by factors such as trust in AI systems, integration with existing workflows, system understanding, and technology receptiveness, rather than aesthetic aspects like the color of the machines |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
What role does social influence play in AI acceptability in healthcare according to the article?
|
Affects healthcare professionals’ decisions to use AI |
|
According to the article, social influence Affects Healthcare Professionals’ Decisions To Use AI. Social influence can impact how professionals perceive AI, including their willingness to adopt and integrate AI technologies into their practices based on peer opinions, institutional norms, and societal attitudes. |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What is a perceived threat regarding AI usage in healthcare settings?
|
Concerns about replacing healthcare professionals |
|
A perceived threat regarding AI usage in healthcare settings is Concerns About Replacing Healthcare Professionals. There are apprehensions that AI could potentially reduce the need for human professionals, leading to job displacement and undermining the role of healthcare workers in clinical settings |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
According to the article, what is essential for increasing AI acceptability among medical professionals?
|
Designing human-centred AI systems |
|
According to the article, Designing Human-Centred AI Systems is essential for increasing AI acceptability among medical professionals. This involves creating AI systems that are user-friendly, integrate seamlessly into existing workflows, and address the specific needs and concerns of healthcare professionals |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What does the 'system usage' category of AI acceptability factors include according to the article?
|
Factors like value proposition and integration with workflows |
|
According to the article, the 'system usage' category of AI acceptability factors includes Factors Like Value Proposition And Integration With Workflows. This category focuses on how well the AI system fits into existing practices and processes, and the perceived benefits it provides in terms of efficiency and effectiveness |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
How does ethicality impact AI acceptability among healthcare professionals?
|
Affects views on AI based on compatibility with professional values |
|
Ethicality impacts AI acceptability among healthcare professionals by Affecting Views On AI Based On Compatibility With Professional Values. Healthcare professionals are more likely to accept AI systems that align with their ethical standards and professional values, ensuring that the technology is used in ways that are considered morally and ethically appropriate |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What methodological approach did the article emphasize for future AI acceptability studies?
|
Considering user experience and system integration deeply |
|
The article emphasized Considering User Experience And System Integration Deeply as a methodological approach for future AI acceptability studies. This approach involves understanding how well AI systems fit into the daily practices of healthcare professionals and how user-friendly and integrated the systems are within existing workflows |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What is the primary objective of using human embryonic stem cells in treating Parkinson’s disease?
|
To replace lost dopamine neurons. |
|
The primary objective of using human embryonic stem cells in treating Parkinson’s disease is To Replace Lost Dopamine Neurons. Parkinson’s disease is characterized by the degeneration of dopamine-producing neurons in the brain. Human embryonic stem cells have the potential to differentiate into dopamine neurons, which can then be used to replace the lost or damaged neurons, potentially alleviating symptoms and improving motor function |
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Which animal was used to test the STEM-PD product for safety and efficacy?
|
Monkeys |
|
The animal used to test the STEM-PD product for safety and efficacy was Monkeys. Non-human primates, such as monkeys, are often used in preclinical studies for testing new treatments, including stem cell therapies, due to their physiological and anatomical similarities to humans |
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What was the duration of the preclinical safety study in rats mentioned in the article?
|
6 months |
|
The duration of the preclinical safety study in rats mentioned in the article was 6 Months. This time frame is typically used to assess the safety and potential side effects of new treatments in preclinical models |
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What is the name of the clinical trial phase mentioned for STEM-PD?
|
Phase I/IIa |
|
The clinical trial phase mentioned for STEM-PD is Phase I/IIa. This phase typically involves both the initial assessment of safety and the early evaluation of efficacy in a small group of participants |
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
How is the STEM-PD product manufactured?
|
Under GMP-compliant conditions |
|
The STEM-PD product is manufactured Under GMP-Compliant Conditions. GMP (Good Manufacturing Practice) compliance ensures that the product is produced consistently and meets quality standards, which is crucial for the safety and efficacy of clinical products |
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
According to the article, what confirmed the safety of the STEM-PD product in rats?
|
There were no adverse effects or tumor formation. |
|
According to the article, the safety of the STEM-PD product in rats was confirmed by There Were No Adverse Effects Or Tumor Formation. This finding indicates that the product did not cause harmful side effects or tumor development in the preclinical safety study |
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
What key finding was noted in the efficacy study of STEM-PD in rats?
|
Transplanted cells reversed motor deficits in rats. |
|
In the efficacy study of STEM-PD in rats, the key finding noted was that Transplanted Cells Reversed Motor Deficits In Rats. This result indicates that the stem cells were effective in addressing the motor impairments associated with Parkinson's disease in the preclinical model |
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What specific markers were used to assess the purity of the STEM-PD batch?
|
GIRK2 and ALDH1A1 |
|
The specific markers used to assess the purity of the STEM-PD batch were GIRK2 And ALDH1A1. These markers are associated with dopamine neurons and are used to confirm the presence of these neurons in the stem cell-derived product |
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What role do growth factors like FGF8b and SHH play in the manufacturing process of STEM-PD?
|
They are used in cell patterning for specific neural fates. |
|
In the manufacturing process of STEM-PD, growth factors like FGF8b and SHH Are Used In Cell Patterning For Specific Neural Fates. These factors are crucial for directing the differentiation of stem cells into specific types of neurons, such as dopamine neurons, by influencing their developmental pathways |
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What was a key outcome measured in the preclinical trials for efficacy in rats?
|
Recovery of motor function |
|
A key outcome measured in the preclinical trials for efficacy in rats was Recovery Of Motor Function. This outcome assesses how effectively the STEM-PD product can restore or improve motor skills and abilities that are impaired due to Parkinson's disease |
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|